Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment

NCT03028155 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Peritoneal Carcinomatosis

Interventions

DRUG: Oxaliplatin: BSA-based HIPEC
DRUG: Oxaliplatin: Concentration-based HIPEC

Sponsor

Hasselt University

Collaborators

[object Object]